Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
P2RY8-CRLF2 fusion
i
Other names:
CRLF2, Cytokine Receptor Like Factor 2, Thymic Stromal Lymphopoietin Protein Receptor, Cytokine Receptor-Like Factor 2, TSLP Receptor, IL-XR, TSLPR, CRL2, Thymic Stromal-Derived Lymphopoietin Receptor, Cytokine Receptor CRL2 Precusor, Cytokine Receptor-Like 2, CRLF2Y, ILXR, P2RY8, P2Y Receptor Family Member 8, Purinergic Receptor P2Y G-Protein Coupled 8, Purinergic Receptor P2Y8, P2Y Purinoceptor 8, P2Y8, G-Protein Coupled Purinergic Receptor P2Y8
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
64109
;
286530
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
CRLF2 rearrangement (4)
CRLF2 mutation (1)
JAK2 mutation + CRLF2 rearrangement (1)
CRLF2 rearrangement (4)
CRLF2 mutation (1)
JAK2 mutation + CRLF2 rearrangement (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
P2RY8-CRLF2 fusion
Acute Myelogenous Leukemia
P2RY8-CRLF2 fusion
Acute Myelogenous Leukemia
ipilimumab
Sensitive: C4 – Case Studies
ipilimumab
Sensitive
:
C4
ipilimumab
Sensitive: C4 – Case Studies
ipilimumab
Sensitive
:
C4
P2RY8-CRLF2 fusion
B Acute Lymphoblastic Leukemia
P2RY8-CRLF2 fusion
B Acute Lymphoblastic Leukemia
JQ-1
Sensitive: D – Preclinical
JQ-1
Sensitive
:
D
JQ-1
Sensitive: D – Preclinical
JQ-1
Sensitive
:
D
P2RY8-CRLF2 fusion
Acute Lymphocytic Leukemia
P2RY8-CRLF2 fusion
Acute Lymphocytic Leukemia
ruxolitinib
Sensitive: D – Preclinical
ruxolitinib
Sensitive
:
D
ruxolitinib
Sensitive: D – Preclinical
ruxolitinib
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.